S
FATE icon

SignatureFD’s Fate Therapeutics FATE Stock Holding History

SignatureFD’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-422
Closed -$1.48K – 3333
2024
Q3 		$1.48K Sell
422
-53
-11% -$206 ﹤0.01% 2910
2024
Q2 		$1.56K Sell
475
-388
-45% -$1.7K ﹤0.01% 2818
2024
Q1 		$6.33K Buy
863
+503
+140% +$3.11K ﹤0.01% 2472
2023
Q4 		$1.35K Sell
360
-624
-63% -$1.47K ﹤0.01% 2857
2023
Q3 		$2.09K Sell
984
-3,070
-76% -$10.2K ﹤0.01% 2761
2023
Q2 		$19.3K Buy
4,054
+855
+27% +$4.72K ﹤0.01% 1914
2023
Q1 		$18.2K Buy
3,199
+918
+40% +$5.54K ﹤0.01% 1918
2022
Q4 		$23K Buy
2,281
+1,130
+98% +$21.2K ﹤0.01% 1735
2022
Q3 		$26K Buy
1,151
+81
+8% +$2.34K ﹤0.01% 1611
2022
Q2 		$27K Buy
1,070
+199
+23% +$5.49K ﹤0.01% 1621
2022
Q1 		$34K Buy
871
+283
+48% +$11K ﹤0.01% 1558
2021
Q4 		$34K Sell
588
-313
-35% -$17.7K ﹤0.01% 1524
2021
Q3 		$53K Sell
901
-6
-0.7% -$471 ﹤0.01% 1270
2021
Q2 		$79K Buy
907
+715
+372% +$57.6K ﹤0.01% 1061
2021
Q1 		$16K Hold
192
– – ﹤0.01% 1648
2020
Q4 		$17K Sell
192
-11
-5% -$683 ﹤0.01% 1511
2020
Q3 		$8K Buy
203
+48
+31% +$1.68K ﹤0.01% 1715
2020
Q2 		$5K Hold
155
– – ﹤0.01% 1795
2020
Q1 		$3K Buy
+155
New +$3.92K ﹤0.01% 1814

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SignatureFD's FATE Position: Q4 2024 in Review

SignatureFD sold out of Fate Therapeutics (FATE) in Q4 2024, closing a stake of 422 shares — an estimated $1.48K sold.

SignatureFD first reported a position in FATE in Q1 2020 and held it in 19 quarters. The position peaked at $79K in Q2 2021. 159 funds tracked by Wall St. Rank hold FATE as of Q4 2024.

  • SignatureFD reported no remaining Fate Therapeutics position as of Q4 2024 after selling out during the quarter.
  • SignatureFD sold 422 Fate Therapeutics shares in Q4 2024, an estimated $1.48K.
  • SignatureFD first reported a position in Fate Therapeutics in Q1 2020 and held it in 19 quarters.
  • SignatureFD's Fate Therapeutics position peaked at $79K in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2024.

Based on SignatureFD's 13F filing for Q4 2024, filed 10 Feb 2025.